Karl Anton Kreuzer

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 291 citations · Full text

Medicine, Hematology, Oncology +16

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Christian P. Pallasch, Ilya Leskov, Christian Braun et al. · Cell · 2014 · 179 citations · Full text

Medicine, Immunology, Oncology +14

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst, Anna Maria Fink, Raymonde Busch et al. · Blood · 2014 · 117 citations

Medicine, Oncology, Pharmacotherapy +15

Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection

Markus P. Look, Jürgen K. Rockstroh, Govind S. Rao et al. · Biological Trace Element Research · 1997 · 105 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

TH1 to TH2 Shift of Cytokines in Peripheral Blood of HIV-Infected Patients Is Detectable by Reverse Transcriptase Polymerase Chain Reaction but Not by Enzyme-Linked Immunosorbent Assay Under Nonstimulated Conditions

Marcus Altfeld, Marylyn M. Addo, Karl Anton Kreuzer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 46 citations

Veterinary Medicine, Immunology, Infectious Diseases +15